SOD1 and uterine disorder: Therefore, in addition to the oxidative stimulus associated with the uterine disorder, prostaglandin-induced myometrial activity represents an additional factor requiring enzymatic neutralization; consequently, no oscillatory SOD consumption pattern was detected during combined therapy.